NovaBridge Biosciences Financial Ratios — NBP Stock

Profitability (USD)

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	-46.4	-65.26	-62.54	-10.02	-21.42
Return on Assets (%)	- -	-23.31	-69.9	11.84	-39.58	-50.51	-43.31	-7.64	-19.56
Return on Capital (%)	- -	- -	- -	24.42	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	8.43	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	47.25	354.53	100	- -	- -
EBITDA Margin (%)	-2,417.11	-801.67	-4,829.22	12.34	-2,303.81	3,330.95	-7,581.49	- -	- -
Operating Margin (%)	-2,431.25	-814.21	-4,881.33	10.84	-2,342.59	3,422.18	-7,749.37	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	101.32	- -	-1,760.52	- -	387.66	- -
Pretax Margin (%)	-2,580.82	-745.82	-4,839.83	31.32	-2,652.28	9,097.36	-13,009.02	- -	- -
Profit Margin (%)	-2,580.82	-749.02	-4,839.83	30.53	-2,648.7	23,923.47	-32,868.51	- -	- -
Net Income to Common Margin (%)	-2,580.82	-749.02	-4,950	30.53	-2,648.7	23,923.47	-32,868.51	- -	- -
Effective Tax Rate (%)	- -	- -	- -	2.53	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	2.23	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	-46.4	-65.26	-62.54	-10.02	-21.42

Credit (USD)

Credit Ratios API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	33	21	19	2	18	11	4	4	3
ST Debt	15	12	8	1	5	6	1	1	1
LT Debt	17	10	11	1	13	5	3	3	2
Total Debt/EBITDA	-0.76	-0.34	-0.09	0.07	-0.06	-0.21	-0.08	-0.08	-0.03
Net Debt/EBITDA	0.34	3.34	0.7	-25	1.74	8.96	5.82	1.35	2.25
Total Debt/EBIT	-0.76	-0.34	-0.09	0.08	-0.05	-0.2	-0.08	-0.08	-0.03
Net Debt/EBIT	0.34	3.29	0.7	-28.46	1.71	8.72	5.7	1.33	2.23
EBITDA to Interest Expense	-49.5	-36.87	-484.38	198.89	- -	-39,604.28	-470.43	- -	- -
EBITDA-CapEx/Interest Expense	-53.1	-38.1	-488.47	190.52	- -	-41,207.22	-472.04	- -	- -
EBIT to Interest Expense	-49.79	-37.44	-489.6	174.72	- -	-40,689.01	-480.85	- -	- -
Interest Expense	1	2	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-29.24	-40.2	-117.1	88.84	81.4	71.43	65.75	94.58	88.65
Long-Term Debt/Equity (%)	- -	- -	- -	0.1	1.79	1.1	1.34	1.52	0.94
Long-Term Debt/Capital (%)	-131.36	-8.29	-3.98	0.1	1.75	1.07	1.32	1.5	0.93
Long-Term Debt/Total Assets (%)	11.12	2.82	4.36	0.09	1.46	0.79	0.88	1.44	0.84
Total Debt/Equity (%)	-71.05	-15.39	-6.51	0.24	2.47	2.58	1.6	1.93	1.33
Total Debt/Capital (%)	-245.43	-18.19	-6.97	0.24	2.41	2.51	1.58	1.89	1.31
Total Debt/Total Assets (%)	20.77	6.19	7.63	0.21	2.01	1.84	1.05	1.83	1.18
Net Debt to Equity	31.66	150.9	50.09	-84.57	-77.28	-109.8	-115	-33.93	-91.21
Net Debt/Capital (%)	24.05	60.14	33.53	-539.56	-306.83	1,394.51	619.45	-49.91	-901.06
EBITDA	-43	-63	-207	29	-318	-52	-48	-50	-93
EBITDA-CapEx	-46	-65	-209	28	-323	-54	-48	-50	-93
Operating Income (Loss)	-43	-64	-209	26	-324	-53	-49	-51	-94

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	2.94	5.33	1.99	8.31	6.85	4.55	5.36	20.51	7.84
Current Ratio	3.54	5.88	2.31	9.28	7.66	4.78	5.67	20.9	8.09
Quick Ratio	2.96	5.4	2.08	9.12	7.48	4.59	5.39	20.65	7.91
CFO/Avg Current Liab	- -	-1.02	-1.85	0.77	-1.64	-0.48	-0.87	-1.58	-1.17
Common Equity/Total Assets	-29.24	-40.2	-117.1	88.84	81.4	71.43	65.75	94.58	88.65
Long-Term Debt/Equity (%)	- -	- -	- -	0.1	1.79	1.1	1.34	1.52	0.94
Long-Term Debt/Capital (%)	-131.36	-8.29	-3.98	0.1	1.75	1.07	1.32	1.5	0.93
Long-Term Debt/Total Assets (%)	11.12	2.82	4.36	0.09	1.46	0.79	0.88	1.44	0.84
Total Debt/Equity (%)	-71.05	-15.39	-6.51	0.24	2.47	2.58	1.6	1.93	1.33
Total Debt/Capital (%)	-245.43	-18.19	-6.97	0.24	2.41	2.51	1.58	1.89	1.31
Total Debt/Total Assets (%)	20.77	6.19	7.63	0.21	2.01	1.84	1.05	1.83	1.18
CFO/Total Liabilities	-19.03	-8.43	-23.01	61.35	-93.42	-29.39	-57.54	-457.2	-69.63
CFO/CapEx	-12.41	-19.48	-70.91	54.14	-32.51	-23.71	-443.27	-1,097.27	-2,942.43
Altman's Z-Score	-1.15	-0.38	-5.17	282.33	201.76	17.64	7.34	52.28	142.38

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	23.64	1.1	-0.6	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	15.44	332.55	-610.68	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	3.41	1.85	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	107.05	197.54	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	439.6	-413.14	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	225.49	-808.21	- -	- -	- -
Inventories	- -	- -	- -	- -	4	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	4	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	50,747	55,354	5,506	2,504	1,163	7,388
- Cash & Cash Equivalents	47	231	163	728	553	466	292	68	211
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	33	21	19	2	18	11	4	4	3
Enterprise Value	-55	-247	-148	50,016	54,700	5,017	2,196	994	7,180
Total Capital	-13	-117	-272	863	733	433	246	205	234
Total Debt/Capital (%)	-245.43	-18.19	-6.97	0.24	2.41	2.51	1.58	1.89	1.31
Total Debt / EV	-0.59	-0.09	-0.13	- -	- -	- -	- -	- -	- -
EV/Sales	7,921.27	497,522.56	- -	211.82	3,960.93	- -	3,474.68	- -	- -
EV/EBITDA	- -	- -	- -	1,716.78	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	1,954.34	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	752.08	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	738.47	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	21,039	22,873	2,380	1,196	504	2,666
Diluted Enterprise Value	-15	-210	-144	20,313	22,338	1,925	908	439	2,459
EV per Share	314.9	87,360.89	- -	303.33	297.56	26.28	11.83	5.3	27.06
TTM Sales	2	8	4	236	14	-2	1	- -	- -
TTM EBITDA	-43	-63	-207	29	-318	-52	-48	-50	-93
TTM Operating Income	-43	-64	-209	26	-324	-53	-49	-51	-94
TTM Cash Flow to Firm	-38	-39	-124	67	-153	-50	-73	-53	-21
TTM Free Cash Flow to Firm	-35	-37	-122	68	-148	-47	-72	-53	-21

Multiples (USD)

Valuation Multiples API ChatGPT

	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	311.29	-154.58	-50.12	-16.49	-9.58	-129.48
EV/EBIT	- -	- -	- -	1,954.34	- -	- -	- -	- -	- -
Enterprise Value	-55	-247	-148	50,016	54,700	5,017	2,196	994	7,180
Low Price	- -	- -	- -	65.08	262.27	22.27	8.48	6.14	4.33
EV/Sales	7,921.27	497,522.56	- -	211.82	3,960.93	- -	3,474.68	- -	- -
EV/EBITDA	- -	- -	- -	1,716.78	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	249.06	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	150.39	-84.71	-17.72	-8.76	-39.27	-37.96
Price/Earnings High	- -	- -	- -	260.88	-114.54	-67.47	-22.17	-66.34	-100.18
Price/Earnings Low	- -	- -	- -	52.67	-54.46	-4.95	-3.62	-22.43	-8.97
Price/Book Value	- -	- -	- -	58.92	77.38	13.05	10.32	5.78	31.99
Price/Book Value Average	- -	- -	- -	35.58	104.83	36.06	15.7	10.02	21.07
Price/Book Value High	- -	- -	- -	61.72	141.74	137.31	39.76	16.93	55.62
Price/Book Value Low	- -	- -	- -	12.46	67.4	10.08	6.49	5.72	4.98
Price/Tangible Book Value	- -	- -	- -	62.04	82.49	14.45	11.08	5.78	31.99
Price/Tangible Book Value Average	- -	- -	- -	37.46	111.75	39.92	16.85	10.02	21.07
Price/Tangible Book Value High	- -	- -	- -	64.98	151.1	152.02	42.69	16.93	55.62
Price/Tangible Book Value Low	- -	- -	- -	13.12	71.85	11.16	6.97	5.72	4.98
Price/Sales	- -	- -	- -	76.03	1,656.26	-1,534.64	1,892.25	- -	- -
Price/Sales Average	- -	- -	- -	45.91	2,243.81	-4,239.17	2,877.77	- -	- -
Price/Sales High	- -	- -	- -	79.64	3,033.84	-16,141.78	7,288.39	- -	- -
Price/Sales Low	- -	- -	- -	16.08	1,442.58	-1,184.74	1,189.99	- -	- -
Price/Cash Flow	- -	- -	- -	270.52	-149.83	-48.01	-16.45	-9.57	-129.44
Price/Cash Flow Average	- -	- -	- -	163.35	-202.97	-132.61	-25.02	-16.57	-85.27
Price/Cash Flow High	- -	- -	- -	283.36	-274.44	-504.94	-63.36	-28	-225.05
Price/Cash Flow Low	- -	- -	- -	57.2	-130.5	-37.06	-10.35	-9.47	-20.15
Price/Free Cash Flow Average	- -	- -	- -	187.97	-209.42	-138.45	-25.07	-16.59	-85.3
Price/Free Cash Flow High	- -	- -	- -	326.07	-283.15	-527.17	-63.51	-28.03	-225.12
Price/Free Cash Flow Low	- -	- -	- -	65.83	-134.64	-38.69	-10.37	-9.47	-20.16
EV/Sales Average	509,273.32	25,362.7	- -	126.7	5,391.39	- -	5,570.05	- -	- -
EV/Sales High	3,142,137.38	497,527.32	- -	222.04	7,303.33	- -	14,804.5	- -	- -
EV/Sales Low	670.29	1,690.52	- -	42.37	3,452.39	- -	2,036.37	- -	- -
EV/EBITDA Average	0.34	3.34	0.69	1,026.86	-234.02	-285.59	-73.47	-38.68	-49.88
EV/EBITDA High	0.34	3.34	0.69	1,799.62	-317.01	-1,112.19	-195.27	-66.22	-135.29
EV/EBITDA Low	0.34	3.34	0.69	343.41	-149.86	-73.47	-26.86	-21.54	-10.09
EV/EBIT Average	0.34	3.29	0.69	1,168.95	-230.15	-277.98	-71.88	-37.94	-49.43
EV/EBIT High	0.34	3.29	0.69	2,048.64	-311.76	-1,082.54	-191.04	-64.96	-134.06
EV/EBIT Low	0.34	3.29	0.69	390.92	-147.37	-71.51	-26.28	-21.13	-10
Last Price	- -	- -	- -	307.77	301.12	28.85	13.49	6.21	27.84
High Price	- -	- -	- -	322.37	551.57	303.41	51.96	18.16	48.4
Enterprise Value Average	-15	-210	-144	29,916	74,455	14,754	3,520	1,951	4,660
Enterprise Value High	-15	-210	-144	52,430	100,859	57,459	9,356	3,341	12,638
Enterprise Value Low	-15	-210	-144	10,005	47,677	3,796	1,287	1,087	942

Shares Outstanding	133	133	133	165	184	191	186	187	265
Diluted Weighted Avg Shares	45	45	58	68	76	83	89	81	96
Basic Weighted Avg Shares	45	45	58	58	76	83	89	81	96
Revenue per Share	0.04	0.18	0.07	4.05	0.18	-0.02	0.01	- -	- -
EBITDA per Share	-0.96	-1.41	-3.58	0.5	-4.19	-0.63	-0.54	-0.62	-0.98
Operating Income per Share	-0.97	-1.43	-3.62	0.44	-4.26	-0.64	-0.55	-0.63	-0.98
Basic EPS, GAAP	-1.03	-1.32	-3.67	1.24	-4.82	-4.5	-2.34	-0.27	-0.48
Basic EPS from Cont Ops	-1.03	-1.32	-3.59	1.24	-4.82	-1.71	-0.93	-0.61	-0.92
Diluted EPS, GAAP	-1.03	-1.32	-3.67	1.05	-4.82	-4.5	-2.34	-0.27	-0.48
Diluted EPS from Cont Ops	-1.03	-1.32	-3.59	1.05	-4.82	-1.71	-0.93	-0.61	-0.92
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.87	-0.92	-2.15	1.14	-2.01	-0.6	-0.82	-0.65	-0.22
Free Cash Flow per Basic Share	-0.94	-0.96	-2.18	1.12	-2.07	-0.63	-0.82	-0.65	-0.22
Cash & Equivalents per Share	0.66	2.02	1.26	4.45	3.65	2.62	1.68	0.93	0.79
Book Value per Share	-0.35	-1.04	-2.19	5.22	3.89	2.21	1.31	1.07	0.87
Tangible Book Value per Share	-0.7	-1.38	-2.52	4.96	3.65	2	1.22	1.07	0.87

NovaBridge Biosciences

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)